Home › Carmentix, U of Melbourne Launch Prenatal Biomarkers Initiative

Carmentix, U of Melbourne Launch Prenatal Biomarkers Initiative

Dec 12, 2016

NEW YORK (GenomeWeb) – Singapore-based company Carmentix Private Limited and Australia's University of Melbourne announced a new initiative last week to discover biomarkers related to preterm birth.

"Carmentix is excited to begin this collaboration, as we are keen to further develop the biomarkers discovered on our unique data mining platform," CEO Nir Arbel said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

What's Popular?

In Molecular Diagnostics

  1. Danaher Q2 Revenues Grow 6 Percent; MDx Product Line Shut Down

  2. Startup SpinDiag Raises €1.6M in Seed Funding

  3. Courtagen Closes Genetic Testing Business, Citing Regulatory, Reimbursement Challenges

  4. NanoVelcro Microchips Can Capture Fetal Cells from Maternal Blood for Prenatal Genetic Testing

    Premium

  5. Abbott Dx Revenues Rise 4 Percent in Q2 on Strong Core Lab and Point-of-Care Growth

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.